CH396845A - Verfahren zur Verbesserung der physikalischen Eigenschaften von Koazervatmembranen - Google Patents

Verfahren zur Verbesserung der physikalischen Eigenschaften von Koazervatmembranen

Info

Publication number
CH396845A
CH396845A CH8206059A CH8206059A CH396845A CH 396845 A CH396845 A CH 396845A CH 8206059 A CH8206059 A CH 8206059A CH 8206059 A CH8206059 A CH 8206059A CH 396845 A CH396845 A CH 396845A
Authority
CH
Switzerland
Prior art keywords
coacervate
membranes
improving
physical properties
physical
Prior art date
Application number
CH8206059A
Other languages
English (en)
Inventor
Hugo Jensen Erik
Original Assignee
Ncr Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ncr Co filed Critical Ncr Co
Publication of CH396845A publication Critical patent/CH396845A/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • A01N25/28—Microcapsules or nanocapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/10—Complex coacervation, i.e. interaction of oppositely charged particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dentistry (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Agronomy & Crop Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Colloid Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
CH8206059A 1958-12-22 1959-12-19 Verfahren zur Verbesserung der physikalischen Eigenschaften von Koazervatmembranen CH396845A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78193058A 1958-12-22 1958-12-22

Publications (1)

Publication Number Publication Date
CH396845A true CH396845A (de) 1965-08-15

Family

ID=25124414

Family Applications (1)

Application Number Title Priority Date Filing Date
CH8206059A CH396845A (de) 1958-12-22 1959-12-19 Verfahren zur Verbesserung der physikalischen Eigenschaften von Koazervatmembranen

Country Status (3)

Country Link
CH (1) CH396845A (de)
DE (1) DE1141263B (de)
GB (2) GB929406A (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965033A (en) * 1970-07-27 1976-06-22 Fuji Photo Film Co., Ltd. Process for the production of oil-containing microcapsules
CA1044134A (en) * 1975-04-09 1978-12-12 Minnesota Mining And Manufacturing Company Microcapsule insecticide composition
FR2464093A1 (fr) * 1979-08-30 1981-03-06 Roussel Uclaf Procede de preparation de suspensions ou de poudres stables de microcapsules stables et d'une porosite variable et les produits ainsi obtenus
DE3016170A1 (de) 1980-04-26 1981-10-29 Bayer Ag, 5090 Leverkusen Mikrokapseln mit definierter oeffnungstemperatur, verfahren zu deren herstellung sowie deren verwendung
US4808408A (en) * 1983-05-11 1989-02-28 Bend Research, Inc. Microcapsules prepared by coacervation
EP1220657A1 (de) * 1999-10-14 2002-07-10 1170535 Ontario Inc. In liposomen verkapselte silbersalzhaltige arzneimittel
FR2857592B1 (fr) * 2003-07-18 2006-02-24 Sod Conseils Rech Applic Nouveau procede de preparation de microparticules
ES2400687T3 (es) 2004-04-23 2013-04-11 Amgen Inc. Formulaciones de liberación sostenida
US9822364B2 (en) 2008-03-11 2017-11-21 Yale University Compositions and methods for controlled delivery of inhibitory ribonucleic acids
US9339529B2 (en) 2012-02-17 2016-05-17 Massachusetts Institute Of Technology Glucose-responsive microgels for closed loop insulin delivery
AU2013232297B2 (en) 2012-03-16 2016-01-14 The Johns Hopkins University Controlled release formulations for the delivery of HIF-1 inhibitors
WO2013138346A1 (en) 2012-03-16 2013-09-19 The Johns Hopkins University Non-linear multiblock copolymer-drug conjugates for the delivery of active agents
WO2014160404A1 (en) 2013-03-13 2014-10-02 The Regents Of The University Of California Improved oral drug devices and drug formulations
JP2017503860A (ja) 2014-01-10 2017-02-02 チャンバー ワークス，エルエルシー 皮膚への適用または刺青インクへの添加のための個別化物質およびその製造方法
WO2015138951A1 (en) 2014-03-14 2015-09-17 Chamber Works, Llc Articles of jewelry containing a personalizing additive such as dna and methods of making
US10722468B2 (en) 2014-08-14 2020-07-28 Brown University Compositions for stabilizing and delivering proteins
JP6882186B2 (ja) 2014-12-15 2021-06-02 ザ ジョーンズ ホプキンズ ユニバーシティＴｈｅ Ｊｏｈｎｓ Ｈｏｐｋｉｎｓ Ｕｎｉｖｅｒｓｉｔｙ スニチニブ製剤及び眼の障害の治療におけるその使用に対する方法
US20180008718A1 (en) 2015-01-20 2018-01-11 The Johns Hopkins University Compositions for the sustained release of anti-glaucoma agents to control intraocular pressure
ES2908479T3 (es) 2015-08-26 2022-04-29 Achillion Pharmaceuticals Inc Compuestos para el tratamiento de trastornos inmunitarios e inflamatorios
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
CA2997442C (en) 2015-09-04 2021-01-26 Yale University Polymeric bile acid nanocompositions targeting the pancreas and colon
BR112018009644A2 (pt) 2015-11-12 2018-11-06 Graybug Vision Inc micropartículas agregantes sólidas modificadas na superfície, material injetável, processo para preparação de micropartículas agregantes sólidas modificadas na superfície, método para tratamento de um distúrbio ocular, e, uso de micropartículas agregantes sólidas modificadas na superfície
AU2017221424A1 (en) 2016-02-16 2018-09-20 Yale University Compositions and methods for treatment of cystic fibrosis
US11136597B2 (en) 2016-02-16 2021-10-05 Yale University Compositions for enhancing targeted gene editing and methods of use thereof
US20190022016A1 (en) 2016-03-02 2019-01-24 The Johns Hopkins University Compositions for sustained release of anti-glaucoma agents to control intraocular pressure
RU2018145364A (ru) 2016-06-27 2020-07-28 Ачиллион Фармасьютикалс, Инк. Хиназолиновые и индольные соединения для лечения медицинских нарушений
WO2018053010A1 (en) 2016-09-13 2018-03-22 North Carolina State University Platelet compositions and methods for the delivery of therapeutic agents
WO2018187493A1 (en) 2017-04-04 2018-10-11 Yale University Compositions and methods for in utero delivery
AU2018265415A1 (en) 2017-05-10 2019-10-31 Graybug Vision, Inc. Extended release microparticles and suspensions thereof for medical therapy
WO2020028907A1 (en) 2018-08-03 2020-02-06 Brown University Compositions and methods for improving the bioavailability of glp1 and analogues thereof
WO2020033951A1 (en) 2018-08-10 2020-02-13 Yale University Compositions and methods for embryonic gene editing in vitro
JP2023532204A (ja) 2020-06-19 2023-07-27 イェール ユニバーシティー 抗原特異的寛容を誘導する免疫調節剤を含むポリマー胆汁酸エステルナノ粒子
US20240042024A1 (en) 2020-11-27 2024-02-08 David A. Horwitz Methods and compositions for treatment of immune-mediated diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2800457A (en) * 1953-06-30 1957-07-23 Ncr Co Oil-containing microscopic capsules and method of making them

Also Published As

Publication number Publication date
GB929406A (en) 1963-06-19
GB929405A (en) 1963-06-19
DE1141263B (de) 1962-12-20

Similar Documents

Publication Publication Date Title
CH396845A (de) Verfahren zur Verbesserung der physikalischen Eigenschaften von Koazervatmembranen
CH395033A (de) Verfahren zur Verminderung der Durchlässigkeit von Überzügen
CH411921A (de) Verfahren zur Herstellung von Aminoacetonitrilen
CH388622A (de) Verfahren zur Herstellung von Mischpolymerisaten
CH374653A (de) Verfahren zur Cyclisierung von Pseudojononen
CH417965A (de) Verfahren zur Herstellung von Heteroblock-Copolymeren
CH397677A (de) Verfahren zur Herstellung von Aroylalkylpiperidinen
CH396846A (de) Verfahren zur Verminderung der Durchlässigkeit von Überzügen
CH409892A (de) Verfahren zur Herstellung von Peroxo-monosulfaten
CH396844A (de) Verfahren zur Verbesserung der physikalischen Eigenschaften von Koazervatmembranen
CH394758A (de) Verfahren zur Regenerierung von Chromatierungslösungen
CH393273A (de) Verfahren zur Verbesserung der physikalischen Eigenschaften von Koazervatmembranen
CH390234A (de) Verfahren zur Herstellung von Vinylthioäthylthiolphosph3r- bzw, -phosphonsäureestern
CH408015A (de) Verfahren zur Herstellung von 3-Nitro-azacyclo-alkanon-2-N-carbochloriden
CH351108A (de) Verfahren zur Herstellung von Mischpolymerisaten
CH375362A (de) Verfahren zur Herstellung von 4-Chinazolonen
CH400993A (de) Verfahren zur Verbesserung der mechanischen Eigenschaften von cellulosehaltigem Textilgut
CH387645A (de) Verfahren zur Herstellung von Rhodantriazinen
CH377358A (de) Verfahren zur Herstellung von Di-alkylenimiden
CH417104A (de) Verfahren zur Herstellung von Eupolyoxymethylenen
CH358070A (de) Verfahren zur Anreichung von Isotopen
CH397672A (de) Verfahren zur Herstellung von Tetraorganodiphosphinen
CH369133A (de) Verfahren zur Herstellung von substituierten Tetrahydro-oxazinen
CH378880A (de) Verfahren zur Herstellung von Reichsteins-Substanz-S
CH394229A (de) Verfahren zur Herstellung von 3-Aralkyl-2-tert.-aminoalkyl-indenen